Chart Industries, Inc. 10-Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2007
OR
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number 1-11442
(Exact Name of Registrant as Specified in its Charter)
|
|
|
Delaware
|
|
34-1712937 |
|
|
|
(State or Other Jurisdiction
of Incorporation or Organization)
|
|
(I.R.S. Employer Identification No.) |
One Infinity Corporate Centre Drive, Suite 300, Garfield Heights, Ohio 44125
(Address of Principal Executive Offices) (ZIP Code)
Registrants Telephone Number, Including Area Code: (440) 753-1490
NOT APPLICABLE
(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such
shorter period that the registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in
Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer o Accelerated filer o Non-accelerated filer þ
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act) Yes o No þ
Indicate by check mark whether the registrant has filed all documents and reports required to be
filed by Section 12, 13, or 15 of the Securities Exchange Act of 1934 subsequent to the
distribution of securities under a plan confirmed by a court. Yes þ No o
At July 31, 2007, there were 27,556,263 outstanding shares of the Companys Common Stock, par
value $0.01 per share.
CHART INDUSTRIES, INC.
INDEX
2
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements.
CHART INDUSTRIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in thousands, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
December 31, |
|
|
|
2007 |
|
|
2006 |
|
|
|
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
Current Assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
14,276 |
|
|
$ |
18,854 |
|
Accounts receivable, net |
|
|
92,951 |
|
|
|
76,762 |
|
Inventories, net |
|
|
82,864 |
|
|
|
72,857 |
|
Unbilled contract revenue |
|
|
22,024 |
|
|
|
32,993 |
|
Other current assets |
|
|
31,059 |
|
|
|
26,085 |
|
Assets held for sale |
|
|
3,084 |
|
|
|
3,084 |
|
|
|
|
|
|
|
|
Total Current Assets |
|
|
246,258 |
|
|
|
230,635 |
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
|
92,094 |
|
|
|
85,723 |
|
Goodwill |
|
|
247,000 |
|
|
|
247,144 |
|
Identifiable intangible assets, net |
|
|
140,952 |
|
|
|
146,623 |
|
Other assets, net |
|
|
13,512 |
|
|
|
14,750 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS |
|
$ |
739,816 |
|
|
$ |
724,875 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY |
|
|
|
|
|
|
|
|
Current Liabilities |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
50,482 |
|
|
$ |
48,031 |
|
Customer advances and billings in excess of contract revenue |
|
|
48,388 |
|
|
|
45,200 |
|
Accrued expenses and other current liabilities |
|
|
37,117 |
|
|
|
45,260 |
|
Short-term debt |
|
|
|
|
|
|
750 |
|
|
|
|
|
|
|
|
Total Current Liabilities |
|
|
135,987 |
|
|
|
139,241 |
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
250,000 |
|
|
|
290,000 |
|
Other long-term liabilities |
|
|
72,404 |
|
|
|
75,900 |
|
Shareholders Equity |
|
|
|
|
|
|
|
|
Common stock, par value $.01 per share 150,000,000
shares authorized,
27,548,431 and 25,588,043 shares issued and outstanding
at June 30, 2007 and December 31, 2006, respectively |
|
|
275 |
|
|
|
256 |
|
Additional paid-in capital |
|
|
232,229 |
|
|
|
185,567 |
|
Retained earnings |
|
|
42,015 |
|
|
|
26,389 |
|
Accumulated other comprehensive income |
|
|
6,906 |
|
|
|
7,522 |
|
|
|
|
|
|
|
|
|
|
|
281,425 |
|
|
|
219,734 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY |
|
$ |
739,816 |
|
|
$ |
724,875 |
|
|
|
|
|
|
|
|
The balance sheet at December 31, 2006 has been derived from the audited financial statements at
that date, but does not include all of the information and notes required by U.S. generally
accepted accounting principles for complete financial statements.
See accompanying notes to these unaudited condensed consolidated financial statements. The
accompanying notes are an integral part of these unaudited condensed consolidated financial
statements.
3
CHART INDUSTRIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(Dollars and shares in thousands, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
$ |
167,587 |
|
|
$ |
129,367 |
|
|
$ |
320,050 |
|
|
$ |
250,207 |
|
Cost of sales |
|
|
116,329 |
|
|
|
93,254 |
|
|
|
228,933 |
|
|
|
177,107 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
51,258 |
|
|
|
36,113 |
|
|
|
91,117 |
|
|
|
73,100 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
|
28,753 |
|
|
|
17,693 |
|
|
|
48,198 |
|
|
|
35,155 |
|
Amortization expense |
|
|
2,640 |
|
|
|
3,528 |
|
|
|
5,668 |
|
|
|
7,104 |
|
Employee separation and plant closure costs |
|
|
50 |
|
|
|
69 |
|
|
|
149 |
|
|
|
231 |
|
Loss on disposal of assets, net |
|
|
66 |
|
|
|
|
|
|
|
66 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31,509 |
|
|
|
21,290 |
|
|
|
54,081 |
|
|
|
42,490 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
|
19,749 |
|
|
|
14,823 |
|
|
|
37,036 |
|
|
|
30,610 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expenses (income): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net |
|
|
5,958 |
|
|
|
6,586 |
|
|
|
12,304 |
|
|
|
13,131 |
|
Financing costs amortization |
|
|
416 |
|
|
|
369 |
|
|
|
820 |
|
|
|
739 |
|
Foreign currency expense (income) |
|
|
643 |
|
|
|
(3 |
) |
|
|
289 |
|
|
|
(151 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,017 |
|
|
|
6,952 |
|
|
|
13,413 |
|
|
|
13,719 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations before income taxes
and minority interest |
|
|
12,732 |
|
|
|
7,871 |
|
|
|
23,623 |
|
|
|
16,891 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense |
|
|
4,343 |
|
|
|
2,510 |
|
|
|
8,056 |
|
|
|
5,490 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations before
minority interest |
|
|
8,389 |
|
|
|
5,361 |
|
|
|
15,567 |
|
|
|
11,401 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interest, net of taxes |
|
|
(59 |
) |
|
|
53 |
|
|
|
(59 |
) |
|
|
47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
8,448 |
|
|
$ |
5,308 |
|
|
$ |
15,626 |
|
|
$ |
11,354 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per common share basic |
|
$ |
0.32 |
|
|
$ |
0.56 |
|
|
$ |
0.60 |
|
|
$ |
1.30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per common share diluted |
|
$ |
0.32 |
|
|
$ |
0.50 |
|
|
$ |
0.60 |
|
|
$ |
1.20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares
outstanding basic |
|
|
26,126 |
|
|
|
9,540 |
|
|
|
25,865 |
|
|
|
8,746 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares
outstanding diluted |
|
|
26,588 |
|
|
|
10,636 |
|
|
|
26,199 |
|
|
|
9,461 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to these unaudited condensed consolidated financial statements. The
accompanying notes are an integral part of these unaudited condensed consolidated financial
statements.
4
CHART INDUSTRIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(Dollars in thousands)
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
|
2007 |
|
|
2006 |
|
OPERATING ACTIVITIES |
|
|
|
|
|
|
|
|
Net income |
|
$ |
15,626 |
|
|
$ |
11,354 |
|
Adjustments to reconcile net income to net cash
provided by operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
9,174 |
|
|
|
9,606 |
|
Employee stock and stock option related compensation
expense |
|
|
7,864 |
|
|
|
752 |
|
Financing costs amortization |
|
|
820 |
|
|
|
739 |
|
Other non-cash operating activities |
|
|
265 |
|
|
|
(78 |
) |
Increase (decrease) in cash resulting from changes in
operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(16,445 |
) |
|
|
(2,107 |
) |
Inventory |
|
|
(10,001 |
) |
|
|
(1,242 |
) |
Unbilled contract revenues and other current assets |
|
|
5,260 |
|
|
|
(16,189 |
) |
Accounts payable and other current liabilities |
|
|
(7,330 |
) |
|
|
(765 |
) |
Customer advances and billings in excess of contract
revenue |
|
|
3,143 |
|
|
|
14,346 |
|
|
|
|
|
|
|
|
Net Cash Provided By Operating Activities |
|
|
8,376 |
|
|
|
16,416 |
|
|
|
|
|
|
|
|
|
|
INVESTING ACTIVITIES |
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
(10,591 |
) |
|
|
(7,240 |
) |
Acquisition of business, net of cash acquired |
|
|
|
|
|
|
(15,858 |
) |
Acquisition of minority interest and other assets |
|
|
(1,649 |
) |
|
|
(188 |
) |
|
|
|
|
|
|
|
Net Cash Used In Investing Activities |
|
|
(12,240 |
) |
|
|
(23,286 |
) |
|
|
|
|
|
|
|
|
|
FINANCING ACTIVITIES |
|
|
|
|
|
|
|
|
Net payments on revolving credit facilities or short-term debt |
|
|
(750 |
) |
|
|
(2,350 |
) |
Principal payments on long-term debt |
|
|
(40,000 |
) |
|
|
(30,000 |
) |
Proceeds from exercise of warrants and options |
|
|
|
|
|
|
39,237 |
|
Proceeds from secondary stock offering, net |
|
|
38,061 |
|
|
|
|
|
Contributions from joint venture partners |
|
|
1,328 |
|
|
|
|
|
Other financing activities |
|
|
452 |
|
|
|
|
|
|
|
|
|
|
|
|
Net Cash (Used In) Provided By Financing Activities |
|
|
(909 |
) |
|
|
6,887 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash and cash equivalents |
|
|
(4,773 |
) |
|
|
17 |
|
Effect of exchange rate changes on cash |
|
|
195 |
|
|
|
254 |
|
Cash and cash equivalents at beginning of period |
|
|
18,854 |
|
|
|
11,326 |
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS AT END OF PERIOD |
|
$ |
14,276 |
|
|
$ |
11,597 |
|
|
|
|
|
|
|
|
See accompanying notes to these unaudited condensed consolidated financial statements. The
accompanying notes are an integral part of these unaudited condensed consolidated financial
statements.
5
CHART INDUSTRIES, INC. AND SUBSIDIARIES
Notes to Unaudited Condensed Consolidated Financial Statements June 30, 2007
(Dollars and shares in thousands, except per share amounts)
NOTE A Basis of Preparation
The accompanying unaudited condensed consolidated financial statements of Chart Industries,
Inc. and its subsidiaries (the Company) have been prepared in accordance with U.S. generally
accepted accounting principles for interim financial information and with the instructions to Form
10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and
footnotes required by U.S. generally accepted accounting principles for annual financial
statements. These financial statements should be read in conjunction with the audited financial
statements and notes thereto included in the Companys Annual Report on Form 10-K for the year
ended December 31, 2006. In the opinion of management, all adjustments (consisting of normal
recurring accruals) considered necessary for a fair presentation have been included. Operating
results for the three and six months ended June 30, 2007 are not necessarily indicative of the
results that may be expected for the year ending December 31, 2007.
Principles of Consolidation: The unaudited condensed consolidated financial statements
include the accounts of the Company and its subsidiaries. Intercompany accounts and transactions
are eliminated in consolidation. Investments in affiliates where the Companys ownership is between
20 percent and 50 percent, or where the Company does not have control, but has the ability to
exercise significant influence over operations or financial policy, are accounted for under the
equity method.
Use of Estimates: The preparation of financial statements in conformity with U.S. generally
accepted accounting principles requires management to make estimates and assumptions that affect
the amounts reported in the financial statements and accompanying notes. Actual results could
differ from those estimates.
Nature of Operations: The Company is a leading global supplier of standard and
custom-engineered products and systems serving a wide variety of low-temperature and cryogenic
applications. The Company has developed an expertise in cryogenic systems and equipment, which
operate at low temperatures sometimes approaching absolute zero. The majority of the Companys
products, including vacuum-insulated containment vessels, heat exchangers, cold boxes and other
cryogenic components, are used throughout the liquid-gas supply chain for the purification,
liquefaction, distribution, storage and end-use of industrial gases and hydrocarbons. The Company
has domestic operations located in eight states, including its principal executive offices located
in Garfield Heights, Ohio, and an international presence in Australia, China, the Czech Republic,
Germany and the United Kingdom.
Basis
of Presentation: On June 12, 2007, the Company completed a
secondary stock offering of
12,612,513 shares. The secondary shares were sold by FR X Chart Holdings LLC and certain members
of the Companys management. As part of the shares sold by members of management, 42,421 stock
options were exercised in conjunction with the offering. The option of 1,891,876 shares to cover
over-allotments granted by the Company to the underwriters was exercised in full. The net proceeds
of $38,061 received by the Company from the exercise of the over-allotment option were used to make
a voluntary principal payment under the term loan portion of the senior secured credit facility.
The consolidated financial statements have been adjusted for the three and six months ended June
30, 2006 to give effect to the 4.6263-for-one stock split of the Companys common stock that
occurred on July 20, 2006, and related adjustments to its capital structure and stock options that
were effected upon the completion of the Companys initial public offering (IPO) on July 31,
2006.
Reclassifications: Certain prior year amounts have been reclassified to conform to the
current year presentation.
Inventories: Inventories are stated at the lower of cost or market with cost being determined
by the first-in, first-out (FIFO) method. The components of inventory are as follows:
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
December 31, |
|
|
|
2007 |
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
Raw materials and supplies |
|
$ |
41,680 |
|
|
$ |
32,404 |
|
Work in process |
|
|
24,105 |
|
|
|
20,974 |
|
Finished goods |
|
|
17,079 |
|
|
|
19,479 |
|
|
|
|
|
|
|
|
|
|
$ |
82,864 |
|
|
$ |
72,857 |
|
|
|
|
|
|
|
|
Revenue Recognition: For the majority of the Companys products, revenue is recognized when
products are shipped, title has transferred and collection is reasonably assured. For these
products, there is also persuasive evidence of an arrangement, and the selling price to the buyer
is fixed or determinable. For brazed aluminum heat exchangers, cold boxes, vacuum-insulated pipe,
liquefied natural gas fueling stations and engineered tanks, the Company uses the percentage of
completion method of accounting. Earned revenue is based on the percentage that incurred costs to
date bear to total estimated costs at completion after giving effect to the most current estimates.
The cumulative impact of revisions in total cost estimates during the progress of work is
reflected in the period in which these changes become known. Earned revenue reflects the original
contract price adjusted for agreed upon claims and change orders, if any. Losses expected
6
CHART INDUSTRIES, INC. AND SUBSIDIARIES
Notes to Unaudited Condensed Consolidated Financial Statements June 30, 2007
(Dollars and shares in thousands, except per share amounts)
NOTE A Basis of Preparation Continued
to be incurred on contracts in process, after consideration of estimated minimum recoveries from
claims and change orders, are charged to operations as soon as such losses are known. Change
orders resulting in additional revenue and profit are recognized upon approval by the customer
based on the percentage that incurred costs to date bear to total estimated costs at completion.
Timing of amounts billed on contracts varies from contract to contract and could cause a
significant variation in working capital requirements.
Product Warranties: The Company provides product warranties with varying terms and durations
for the majority of its products. The Company records warranty expense in cost of sales. The
changes in the Companys consolidated
warranty reserve during the three and six months ended June 30, 2007 and 2006 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Beginning balance |
|
$ |
4,962 |
|
|
$ |
3,760 |
|
|
$ |
4,765 |
|
|
$ |
3,598 |
|
Warranty expense |
|
|
1,165 |
|
|
|
836 |
|
|
|
1,683 |
|
|
|
1,711 |
|
Warranty usage |
|
|
(774 |
) |
|
|
(390 |
) |
|
|
(1,095 |
) |
|
|
(1,103 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance |
|
$ |
5,353 |
|
|
$ |
4,206 |
|
|
$ |
5,353 |
|
|
$ |
4,206 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill and Other Intangible Assets: In accordance with Financial Accounting
Standards Board (FASB) Statement of Financial Accounting Standards (SFAS) No. 141, Business
Combinations, and SFAS No. 142, Goodwill and Other Intangible Assets, the Company does not
amortize goodwill or other indefinite lived intangible assets, but reviews them at least annually
for impairment using a measurement date of October 1st. The Company amortizes intangible assets
that have finite useful lives.
SFAS No. 142 requires that goodwill and other indefinite lived intangible assets be tested for
impairment at the reporting unit level on an annual basis. Under SFAS No. 142, a company
determines the fair value of any indefinite lived intangible assets, compares the fair value to its
carrying value and records an impairment loss if the carrying value exceeds its fair value.
Goodwill is tested utilizing a two-step approach. After recording any impairment losses for
indefinite lived intangible assets, a company is required to determine the fair value of each
reporting unit and compare the fair value to its carrying value, including goodwill, of such
reporting unit (step one). If the fair value exceeds the carrying value, no impairment loss would
be recognized. If the carrying value of the reporting unit exceeds its fair value, the goodwill of
the reporting unit may be impaired. The amount of the impairment, if any, would then be measured
in step two, which compares the implied fair value of reporting unit goodwill with the carrying
amount of that goodwill.
The following table displays the gross carrying amount and accumulated amortization for all
intangible assets.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2007 |
|
|
December 31, 2006 |
|
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
Estimated |
|
|
Carrying |
|
|
Accumulated |
|
|
Carrying |
|
|
Accumulated |
|
|
|
Useful Life |
|
|
Amount |
|
|
Amortization |
|
|
Amount |
|
|
Amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Finite-lived assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unpatented technology |
|
9 years |
|
$ |
9,400 |
|
|
$ |
(1,929 |
) |
|
$ |
9,400 |
|
|
$ |
(1,364 |
) |
Patents |
|
10 years |
|
|
8,138 |
|
|
|
(1,774 |
) |
|
|
8,138 |
|
|
|
(1,287 |
) |
Product names |
|
14 years |
|
|
2,580 |
|
|
|
(360 |
) |
|
|
2,580 |
|
|
|
(255 |
) |
Backlog |
|
14 months |
|
|
6,720 |
|
|
|
(6,720 |
) |
|
|
6,720 |
|
|
|
(6,336 |
) |
Non-compete agreements |
|
3 years |
|
|
3,474 |
|
|
|
(1,414 |
) |
|
|
3,474 |
|
|
|
(977 |
) |
Customer relations |
|
13 years |
|
|
101,066 |
|
|
|
(12,317 |
) |
|
|
101,066 |
|
|
|
(8,647 |
) |
Other |
|
|
|
|
|
|
60 |
|
|
|
(32 |
) |
|
|
60 |
|
|
|
(9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
131,438 |
|
|
$ |
(24,546 |
) |
|
$ |
131,438 |
|
|
$ |
(18,875 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indefinite-lived intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill |
|
|
|
|
|
$ |
247,000 |
|
|
|
|
|
|
$ |
247,144 |
|
|
|
|
|
Trademarks and trade names |
|
|
|
|
|
|
34,060 |
|
|
|
|
|
|
|
34,060 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
281,060 |
|
|
|
|
|
|
$ |
281,204 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7
CHART INDUSTRIES, INC. AND SUBSIDIARIES
Notes to Unaudited Condensed Consolidated Financial Statements June 30, 2007
(Dollars and shares in thousands, except per share amounts)
NOTE A Basis of Preparation Continued
Amortization expense for finite-lived intangible assets was $2,640 and $3,528 for the three months
ended June 30, 2007 and 2006, respectively, and $5,668 and $7,096 for the six months ended June 30,
2007 and 2006, respectively. Amortization expense is estimated to be approximately $10,900 for
2007 and $9,800 for fiscal years 2008 through 2012.
Employee Stock Options: The Company adopted SFAS No. 123(R) Share-Based Payments, using the
modified prospective method, which requires all share-based payments to employees, including grants
of employee stock options, to be recognized in the financial statements based on their fair values.
As of June 30, 2007 and 2006, there were 839 and 861 time-based options and 1,269 and 1,581
performance-based options outstanding under the Amended and Restated 2005 Stock Incentive Plan
(Stock Incentive Plan), respectively. For the three months ended June 30, 2007 and 2006, the
Company recorded $1,240 and $431, respectively, and $1,534 and $752 for the six months ended June
30, 2007 and 2006, respectively, in compensation expense related to the time-based options. As of
June 30, 2007, the total share-based compensation expected to be recognized over the weighted
average period of approximately 3.9 years is $2,382. On June 12, 2007, the Company completed its
secondary stock offering in which First Reserve Fund X, L.P. achieved a return on its investment that
caused 82% of the performance-based options to vest as specified in the Stock Incentive Plan. As a
result of the vesting of the performance-based options, the Company recorded $6,157 in stock-based
compensation expense in the second quarter of 2007.
In May 2007, the Company granted restricted stock units covering 9 shares of common stock to
non-employee directors. Each of the 5 grants has a fair market value of $40 on the date of grant.
In 2006, the Company granted restricted stock units covering 16 shares of common stock to
non-employee directors. Each of the six grants of restricted stock units had a fair market value
of $40 on the date of grant. Restricted stock units for 3 shares were forfeited in the first
quarter of 2007 upon the resignation of a director. The remaining restricted stock units are
expected to fully vest on the first anniversary of the date of grant or earlier in the event of a
change in control as such term is defined in the Stock Incentive Plan, to the extent the grant is
not forfeited upon early resignation of a director. For the three and six months ended June 30,
2007, the Company recorded $71 and $130, respectively, in director compensation expense related to
the restricted stock units.
Recently Issued Accounting Pronouncements: In September 2006, the FASB issued Statement of
Financial Accounting Standards No. 157, Fair Value Measurements (SFAS No. 157) which is effective
for fiscal years beginning after November 15, 2007. SFAS No. 157 defines fair value to be applied
to U.S. GAAP guidance requiring use of fair value, establishes a framework for measuring fair value
and expands the disclosure requirements for fair value measurements. The Company is currently
evaluating the impact of SFAS No. 157 on its financial position and results of operations.
In September 2006, the FASB issued SFAS No. 158, Employers Accounting for Defined Pension
Benefit Plans and Other Postretirement Plans. This statement requires recognition on the balance
sheet of the underfunded or overfunded status of pension and postretirement benefit plans. SFAS
No. 158 also requires the recognition of changes in the funded status through other comprehensive
income in the year that the changes occur. The amount of net periodic benefit cost recognized in
an entitys results of operation will not change. SFAS No. 158 is effective for fiscal years
ending after December 15, 2006. The requirement to measure plan assets and benefit obligations as
of the date of the employers fiscal year end balance sheet is effective for fiscal years ending
after December 15, 2008. The Company adopted SFAS No. 158 as of December 31, 2006. The adoption
of the statement had no effect on our financial position, results of operations, liquidity or cash
flows.
In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets
and Financial Liabilities including an amendment of FASB Statement No. 115. SFAS No. 159
permits entities to choose to measure many financial instruments and certain other items at fair
value that are not currently required to be measured at fair value, with unrealized gains and
losses related to these financial instruments reported in earnings at each subsequent reporting
date. This statement is effective for fiscal years beginning after November 15, 2007. The Company
is currently evaluating the impact of SFAS No. 159 on its financial position and results of
operations.
NOTE B Debt and Credit Arrangements
The Company has a senior secured credit facility (the Senior Credit Facility) and $170,000
of 91/8
% senior subordinated notes (the Subordinated Notes) outstanding. The Senior Credit
Facility consists of a $180,000 term loan facility (the Term Loan) and a $115,000 revolving
credit facility (the Revolver), of which $55,000 may be used for letters of credit extending
beyond one year from their date of issuance. The Term Loan matures on October 17, 2012 and the
Revolver matures on October 17, 2010. The Term Loan does not require any scheduled principal
payments prior to the maturity date. The interest rate under the Senior Credit Facility is, at the
Companys option, the Alternative Base Rate (ABR) plus 1.0% or LIBOR plus 2.0% on the Term Loan
and ABR plus 1.5% or LIBOR plus 2.5% on the Revolver. The applicable interest margin on the
Revolver could decrease based upon the leverage ratio calculated at each fiscal
quarter end. In addition, the Company is required to pay an annual administrative fee of $100, a
commitment fee of 0.5% on the unused Revolver balance, a letter of credit participation fee of 2.5%
per annum on the letter of credit exposure and a
8
CHART INDUSTRIES, INC. AND SUBSIDIARIES
Notes to Unaudited Condensed Consolidated Financial Statements June 30, 2007
(Dollars and shares in thousands, except per share amounts)
NOTE B Debt and Credit Arrangements Continued
letter of credit issuance fee of 0.25%. The obligations under the Senior Credit Facility are
secured by substantially all of the assets of the Company and its U.S. subsidiaries and 65% of the
capital stock of the Companys non-U.S. subsidiaries.
The Subordinated Notes are due in 2015 with interest payable semi-annually on April 15th and
October 15th. The registration rights agreement required the Company to file an Exchange Offer
Registration Statement and complete the exchange offer for the Subordinated Notes by August 14,
2006. Since the exchange offer was not completed when required, additional interest at a rate of
0.50% was incurred for the 90-day period commencing November 12, 2006 and additional interest at a
rate of 0.75% was incurred for the 90-day period commencing February 10, 2007. The exchange offer
was completed on April 6, 2007 and this additional interest ceased accruing as of that date. Any
of the Subordinated Notes may be redeemed solely at the Companys option beginning on October 15,
2010. The initial redemption price is 104.563% of the principal amount, plus accrued interest.
Also, any of the notes may be redeemed solely at the Companys option at any time prior to October
15, 2010, plus accrued interest and a make-whole premium. In addition, before October 15, 2008,
up to 35% of the Subordinated Notes may be redeemed solely at the Companys option at a price of
109.125% of the principal amount, plus accrued interest, using the proceeds from the sales of
certain kinds of capital stock. The Subordinated Notes are general unsecured obligations of the
Company and are subordinated in right of payment to all existing and future senior debt of the
Company, including the Senior Credit Facility, pari passu in right of payment with all future
senior subordinated indebtedness of the Company, and senior in right of payment with any
future indebtedness of the Company that expressly provides for its subordination to the
Subordinated Notes. The Subordinated Notes are unconditionally guaranteed jointly and severally by
substantially all of the Companys U.S. subsidiaries.
The Senior Credit Facility agreement and provisions of the indenture governing the
Subordinated Notes contain a number of customary covenants, including but not limited to
restrictions on the Companys ability to incur additional indebtedness, create liens or other
encumbrances, sell assets, enter into sale and lease-back transactions, make certain payments,
investments, loans, advances or guarantees, make acquisitions, engage in mergers or
consolidations, pay dividends or distributions, and make capital expenditures. The Senior Credit
Facility and indenture governing the Subordinated Notes also include financial covenants relating
to leverage, interest coverage and fixed charge coverage ratios. The Company is in compliance with
all covenants. In June 2007, the Company made a $40,000 voluntary principal payment under the Term
Loan portion of the Senior Credit Facility primarily with proceeds received from the exercise of
the underwriters over-allotment option in conjunction with the
Companys secondary stock offering. As
of June 30, 2007, there was $80,000 outstanding under the Term Loan, $170,000 outstanding under the
Subordinated Notes and letters of credit and bank guarantees totaling $26,997 supported by the
Revolver.
Chart Ferox a.s. (Ferox), a wholly-owned subsidiary of the Company based in the Czech
Republic, maintains secured revolving credit facilities with borrowing capacity, including
overdraft protection, of up to $9,600, of which $4,400 is available only for letters of credit and
bank guarantees. Under the revolving credit facilities, Ferox may make borrowings in Czech
Korunas, Euros and U.S. dollars. Borrowings in Korunas are at PRIBOR, borrowings in Euros are at
EUROBOR and borrowings in U.S. dollars are at LIBOR, each with a fixed margin of 0.6 percent.
Ferox is not required to pay a commitment fee to the lenders under the revolving credit facilities
in respect to the unutilized commitments thereunder. Ferox must pay letter of credit and guarantee
fees equal to 0.75% on the face amount of each guarantee. Feroxs land and buildings and accounts
receivable secure $4,600 and $2,500, respectively, of the revolving credit facilities. As of June
30, 2007, there were no borrowings outstanding under the Ferox revolving credit facilities.
However, there were $2,256 of bank guarantees supported by the Ferox revolving credit facilities.
9
CHART INDUSTRIES, INC. AND SUBSIDIARIES
Notes to Unaudited Condensed Consolidated Financial Statements June 30, 2007
(Dollars and shares in thousands, except per share amounts)
NOTE C Earnings per Share
The following table presents calculations of net income per share of common stock for the
three and six months ended June 30, 2007 and 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Net income (1) |
|
$ |
8,448 |
|
|
$ |
5,308 |
|
|
$ |
15,626 |
|
|
$ |
11,354 |
|
Net income per common share basic |
|
$ |
0.32 |
|
|
$ |
0.56 |
|
|
$ |
0.60 |
|
|
$ |
1.30 |
|
Net income per common share diluted |
|
$ |
0.32 |
|
|
$ |
0.50 |
|
|
$ |
0.60 |
|
|
$ |
1.20 |
|
Weighted average number of common
shares outstanding basic |
|
|
26,126 |
|
|
|
9,540 |
|
|
|
25,865 |
|
|
|
8,746 |
|
Incremental shares issuable upon
assumed exercise of stock warrant |
|
|
|
|
|
|
637 |
|
|
|
|
|
|
|
332 |
|
Incremental shares issuable upon
assumed conversion and exercise of
stock options |
|
|
462 |
|
|
|
459 |
|
|
|
334 |
|
|
|
383 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total shares diluted |
|
|
26,588 |
|
|
|
10,636 |
|
|
|
26,199 |
|
|
|
9,461 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Net income for the three and six months ended June 30, 2007 includes stock-based
compensation of $4,669 ($7,086 before tax) primarily related to the vesting of the performance-based options in conjunction with the
Companys secondary stock offering in June 2007. |
NOTE D Comprehensive Income (Loss)
The components of accumulated other comprehensive income (loss) are as follows:
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
December 31, |
|
|
|
2007 |
|
|
2006 |
|
Foreign currency translation adjustments |
|
$ |
5,736 |
|
|
$ |
6,352 |
|
Minimum pension liability adjustments, net of taxes |
|
|
1,170 |
|
|
|
1,170 |
|
|
|
|
|
|
|
|
|
|
$ |
6,906 |
|
|
$ |
7,522 |
|
|
|
|
|
|
|
|
Comprehensive income for the three months ended June 30, 2007 and 2006 was $8,147 and $7,080,
respectively. Comprehensive income for the six months ended June 30, 2007 and 2006 was $15,010
and $14,576, respectively.
NOTE E Employee Separation and Plant Closure Costs
For the three and six months ended June 30, 2007, the Company recorded employee separation and
plant closure costs of $50 and $149, respectively, primarily related to the closure of the
Distribution and Storage segments idle Plaistow, New Hampshire facility. For the three and six
months ended June 30, 2006, the Company recorded employee separation and plant closure costs of $69
and $231, respectively, primarily related to the closure of the Distribution and Storage segments
idle Plaistow, New Hampshire facility.
The following table summarizes the Companys employee separation and plant closure costs
activity for the three and six months ended June 30, 2007 and 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, 2007 |
|
|
Energy & |
|
Distribution |
|
|
|
|
|
|
Chemicals |
|
& Storage |
|
BioMedical |
|
Total |
|
|
|
One-time employee termination costs |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Other associated costs |
|
|
|
|
|
|
50 |
|
|
|
|
|
|
|
50 |
|
|
|
|
Employee separation and plant closure costs |
|
|
|
|
|
|
50 |
|
|
|
|
|
|
|
50 |
|
Reserve usage |
|
|
|
|
|
|
(50 |
) |
|
|
(34 |
) |
|
|
(84 |
) |
|
|
|
Change in reserve |
|
|
|
|
|
|
|
|
|
|
(34 |
) |
|
|
(34 |
) |
Reserves as of April 1, 2007 |
|
|
1,557 |
|
|
|
190 |
|
|
|
82 |
|
|
|
1,829 |
|
|
|
|
Reserves as of June 30, 2007 |
|
$ |
1,557 |
|
|
$ |
190 |
|
|
$ |
48 |
|
|
$ |
1,795 |
|
|
|
|
10
CHART INDUSTRIES, INC. AND SUBSIDIARIES
Notes to Unaudited Condensed Consolidated Financial Statements June 30, 2007
(Dollars and shares in thousands, except per share amounts)
NOTE E Employee Separation and Plant Closure Costs Continued
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30, 2007 |
|
|
Energy & |
|
Distribution |
|
|
|
|
|
|
Chemicals |
|
& Storage |
|
BioMedical |
|
Total |
|
|
|
One-time employee termination costs |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Other associated costs |
|
|
|
|
|
|
149 |
|
|
|
|
|
|
|
149 |
|
|
|
|
Employee separation and plant closure costs |
|
|
|
|
|
|
149 |
|
|
|
|
|
|
|
149 |
|
Reserve usage |
|
|
|
|
|
|
(149 |
) |
|
|
(73 |
) |
|
|
(222 |
) |
|
|
|
Change in reserve |
|
|
|
|
|
|
|
|
|
|
(73 |
) |
|
|
(73 |
) |
Reserves as of January 1, 2007 |
|
|
1,557 |
|
|
|
190 |
|
|
|
121 |
|
|
|
1,868 |
|
|
|
|
Reserves as of June 30, 2007 |
|
$ |
1,557 |
|
|
$ |
190 |
|
|
$ |
48 |
|
|
$ |
1,795 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, 2006 |
|
|
Energy & |
|
Distribution |
|
|
|
|
|
|
Chemicals |
|
& Storage |
|
BioMedical |
|
Total |
|
|
|
One-time employee termination costs |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Other associated costs |
|
|
|
|
|
|
69 |
|
|
|
|
|
|
|
69 |
|
|
|
|
Employee separation and plant closure costs |
|
|
|
|
|
|
69 |
|
|
|
|
|
|
|
69 |
|
Reserve usage |
|
|
|
|
|
|
(69 |
) |
|
|
(5 |
) |
|
|
(74 |
) |
|
|
|
Change in reserve |
|
|
|
|
|
|
|
|
|
|
(5 |
) |
|
|
(5 |
) |
Reserves as of April 1, 2006 |
|
|
1,557 |
|
|
|
190 |
|
|
|
142 |
|
|
|
1,889 |
|
|
|
|
Reserves as of June 30, 2006 |
|
$ |
1,557 |
|
|
$ |
190 |
|
|
$ |
137 |
|
|
$ |
1,884 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30, 2006 |
|
|
Energy & |
|
Distribution |
|
|
|
|
|
|
Chemicals |
|
& Storage |
|
BioMedical |
|
Total |
|
|
|
One-time employee termination costs |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Other associated costs |
|
|
9 |
|
|
|
222 |
|
|
|
|
|
|
|
231 |
|
|
|
|
Employee separation and plant closure costs |
|
|
9 |
|
|
|
222 |
|
|
|
|
|
|
|
231 |
|
Reserve usage |
|
|
(9 |
) |
|
|
(222 |
) |
|
|
(102 |
) |
|
|
(333 |
) |
|
|
|
Change in reserve |
|
|
|
|
|
|
|
|
|
|
(102 |
) |
|
|
(102 |
) |
Reserves as of January 1, 2006 |
|
|
1,557 |
|
|
|
190 |
|
|
|
239 |
|
|
|
1,986 |
|
|
|
|
Reserves as of June 30, 2006 |
|
$ |
1,557 |
|
|
$ |
190 |
|
|
$ |
137 |
|
|
$ |
1,884 |
|
|
|
|
The employee separation and plant closure costs reserve of $1,795 and $1,884 at June 30,
2007 and 2006, respectively, were for one-time employee termination costs.
NOTE F Acquisitions
On May 26, 2006, the Company acquired the common stock of Cooler Service Company, Inc. (CSC)
based in Tulsa, Oklahoma. The consideration paid was $15,927, net of cash acquired, including
transaction costs. The acquisition was funded with cash on hand. The estimated fair value of the
net assets acquired and goodwill at the date of acquisition was $8,050 and $8,654, respectively.
CSC designs and manufactures air cooled heat exchangers for multiple markets, including
hydrocarbon, petrochemical and industrial gas processing, and power generation. CSC has been
included in the Companys Energy and Chemical segment.
On March 2, 2007, the Company purchased the remaining minority interest in Chart Ferox a.s for
a purchase price of $1,612. The purchase price was applied to eliminate the minority interest in
Ferox a.s. of approximately $2,000. The difference between the purchase price and the value of the
minority interest eliminated was allocated to adjust the fair value of the assets originally
acquired.
NOTE G Assets Held for Sale
The Company has entered into an agreement to sell the idle building and a portion of the land
at its Plaistow, New Hampshire facility. The Company expects to
complete the sale by the end of 2007. The Plaistow facility is classified as assets held for sale on the Companys
unaudited condensed consolidated balance sheet as of June 30, 2007 and the audited consolidated
balance sheet as of December 31, 2006 based on the carrying value of $3,084.
11
CHART INDUSTRIES, INC. AND SUBSIDIARIES
Notes to Unaudited Condensed Consolidated Financial Statements June 30, 2007
(Dollars and shares in thousands, except per share amounts)
NOTE H Income Taxes
The Company adopted the provisions of FASB Interpretation No. 48, Accounting for Uncertainty
in Income Taxes (FIN 48) on January 1, 2007. Previously, the Company had accounted for tax
contingencies in accordance with SFAS No. 5, Accounting for Contingencies. As required by FIN 48,
which clarifies SFAS No. 109, Accounting for Income Taxes, the Company recognizes the financial
statement benefit of a tax position only after determining that the relevant tax authority would
more likely than not sustain the position following an audit. For tax positions meeting the more
likely than not threshold, the amount recognized in the financial statements is the largest benefit
that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the
relevant tax authority. At the adoption date, the Company applied FIN 48 to all tax positions for
which the statute of limitations remained open. As a result of the implementation of FIN 48, the
Company did not recognize material adjustments in the liability for unrecognized tax benefits. The
amount of unrecognized tax benefits as of January 1, 2007 was $3,900. This amount includes $1,100
of unrecognized tax benefits which, if ultimately recognized, will reduce the Companys annual
effective tax rate. There have been no material changes in unrecognized tax benefits since January
1, 2007.
The Company is subject to income taxes in the U.S. federal jurisdiction, and various states
and foreign jurisdictions. Tax regulations within each jurisdiction are subject to the
interpretation of the related tax laws and regulations and require significant judgment to apply.
With no significant exceptions, the Company is no longer subject to U.S. federal, state and local
or non-U.S. income tax examinations by tax authorities for years prior to 2003.
The Internal Revenue Service (IRS) commenced an examination of the Companys U.S. income tax
returns for 2004 and 2005 in January 2007. The Company expects the examination to be concluded and
settled during 2008. The Company is also currently under examination by a number of state tax
authorities. The Company also expects those examinations to be concluded and settled during 2008.
It is reasonably possible that a change in the unrecognized tax benefits may occur, however,
quantification of an estimated range cannot be made at this time.
The Company recognizes interest and penalties related to uncertain tax positions in income tax
expense. The Company had accrued approximately $302 for the payment of interest and penalties at
January 1, 2007 which is included in the unrecognized tax benefits above. During the six months
ended June 30, 2007, the Company accrued approximately $93 in additional interest associated with
uncertain tax positions.
NOTE I Employee Benefit Plans
The Company has four defined benefit pension plans covering certain U.S. hourly and salary
employees. All of these plans were frozen as of February 28, 2006. The defined benefit plans
provide benefits based primarily on the participants years of service and compensation.
The following table sets forth the components of net periodic pension benefit for the three
and six months ended June 30, 2007 and 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
June 30, |
|
June 30, |
|
|
2007 |
|
2006 |
|
2007 |
|
2006 |
|
|
|
|
|
Service cost |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Interest cost |
|
|
523 |
|
|
|
510 |
|
|
|
1,046 |
|
|
|
1,020 |
|
Expected return on plan
assets |
|
|
(680 |
) |
|
|
(618 |
) |
|
|
(1,360 |
) |
|
|
(1,236 |
) |
Recognized actuarial gain |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total pension benefit |
|
$ |
(157 |
) |
|
$ |
(108 |
) |
|
$ |
(314 |
) |
|
$ |
(216 |
) |
|
|
|
|
|
NOTE J Reporting Segments
The structure of the Companys internal organization is divided into the following three
reportable segments: Energy and Chemicals (E&C), Distribution and Storage (D&S) and BioMedical.
The Companys reportable segments are business units that offer different products and are each
managed separately because they manufacture and distribute distinct products with different
production processes and sales and marketing approaches. The E&C segment sells brazed aluminum and
air-cooled heat exchangers, cold boxes and liquefied natural gas vacuum-insulated pipe to natural
gas, petrochemical processing and industrial gas companies who use them for the liquefaction and
separation of natural and industrial gases. The D&S segment sells cryogenic bulk storage systems,
cryogenic packaged gas systems, cryogenic systems and components, beverage liquid CO2 systems and cryogenic services to various
companies for the storage and transportation of both industrial and natural gases. The BioMedical
segment sells medical respiratory products, biological storage systems, other oxygen products and
magnetic resonance imaging cryostat components. Due to the nature of the products that each
segment sells, there are no intersegment sales. Corporate includes operating expenses for
executive management, accounting, tax, treasury, human resources, information technology, legal,
internal audit, risk management and stock-based compensation expenses that are not allocated to the
reporting segments.
12
CHART INDUSTRIES, INC. AND SUBSIDIARIES
Notes to Unaudited Condensed Consolidated Financial Statements June 30, 2007
(Dollars and shares in thousands, except per share amounts)
NOTE J Reporting Segments Continued
The Company evaluates performance and allocates resources based on operating income or loss before
gain on sale of assets, net interest expense, financing costs amortization expense, foreign
currency gain or loss, income taxes and minority interest. The accounting policies of the
reportable segments are described in the summary of significant accounting policies.
Information for the Companys three reportable segments and its corporate headquarters is presented
below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, 2007 |
|
|
Energy |
|
Distribution and |
|
|
|
|
|
|
|
|
& Chemicals |
|
Storage |
|
BioMedical |
|
Corporate |
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
$ |
58,092 |
|
|
$ |
86,562 |
|
|
$ |
22,933 |
|
|
$ |
|
|
|
$ |
167,587 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)(1) |
|
|
9,717 |
|
|
|
19,153 |
|
|
|
4,847 |
|
|
|
(13,968 |
) |
|
|
19,749 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30, 2007 |
|
|
Energy |
|
Distribution and |
|
|
|
|
|
|
|
|
& Chemicals |
|
Storage |
|
BioMedical |
|
Corporate |
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
$ |
110,369 |
|
|
$ |
163,341 |
|
|
$ |
46,340 |
|
|
$ |
|
|
|
$ |
320,050 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss) (1) |
|
|
9,867 |
|
|
|
37,197 |
|
|
|
9,757 |
|
|
|
(19,785 |
) |
|
|
37,036 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, 2006 |
|
|
Energy |
|
Distribution and |
|
|
|
|
|
|
|
|
& Chemicals |
|
Storage |
|
BioMedical |
|
Corporate |
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
$ |
42,490 |
|
|
$ |
66,512 |
|
|
$ |
20,365 |
|
|
$ |
|
|
|
$ |
129,367 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss) |
|
|
1,109 |
|
|
|
14,270 |
|
|
|
4,777 |
|
|
|
(5,333 |
) |
|
|
14,823 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30, 2006 |
|
|
Energy |
|
Distribution and |
|
|
|
|
|
|
|
|
& Chemicals |
|
Storage |
|
BioMedical |
|
Corporate |
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
$ |
83,664 |
|
|
$ |
126,830 |
|
|
$ |
39,713 |
|
|
$ |
|
|
|
$ |
250,207 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss) |
|
|
7,043 |
|
|
|
25,347 |
|
|
|
8,491 |
|
|
|
(10,271 |
) |
|
|
30,610 |
|
|
|
|
(1) |
|
The operating loss for Corporate for the three and six months ended June 30,
2007 includes stock-based compensation of $7,086 primarily related to the vesting of
performance-based options in conjunction with the Companys
secondary stock offering in June 2007. In addition, the
operating loss for Corporate for the three and six months ended
June 30, 2007 includes $510 and $770, respectively, of secondary stock offering
expenses. |
13
CHART INDUSTRIES, INC. AND SUBSIDIARIES
Notes to Unaudited Condensed Consolidated Financial Statements June 30, 2007
(Dollars and shares in thousands, except per share amounts)
NOTE K Supplemental Guarantor Financial Information
The Companys Subordinated Notes issued in October 2005 are guaranteed on a full,
unconditional and joint and several basis by the following wholly owned subsidiaries: Chart Inc.,
CAIRE Inc., Chart Energy and Chemicals, Inc., Chart Cooler Service Company, Inc., Chart
International Holdings, Inc., Chart Asia Inc. and Chart International Inc. The following
subsidiaries are not guarantors of the notes:
|
|
|
Non-Guarantor Subsidiaries |
|
Jurisdiction |
Changzhou CEM Cryo Equipment Co., Ltd.
|
|
China |
Chart Australia Pty. Ltd.
|
|
Australia |
Chart Biomedical Limited
|
|
United Kingdom |
Chart Cryogenic Distribution Equipment (Changzhou) Co., Ltd.
|
|
China |
Chart Cryogenic Engineering Systems (Changzhou) Co., Ltd.
|
|
China |
Chart Cryogenic Equipment (Changzhou) Co., Ltd.
|
|
China |
Chart Ferox a.s.
|
|
Czech Republic |
Chart Ferox GmbH
|
|
Germany |
GTC of Clarksville, LLC
|
|
Delaware |
Lox Taiwan (16% owned)
|
|
Taiwan |
Zhangjigang Chart Hailu Cryogenic Equipment Co., Ltd.
|
|
China |
The following supplemental condensed consolidating and combining financial information of the
Issuer, Subsidiary Guarantors and Subsidiary Non-Guarantors presents statements of operations for
the three and six months ended June 30, 2007 and 2006, balance sheets as of June 30, 2007 and
December 31, 2006 and statements of cash flows for the six months ended June 30, 2007 and 2006.
CONDENSED CONSOLIDATING BALANCE SHEET
As of June 30, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary |
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary |
|
|
Non- |
|
|
Consolidating |
|
|
|
|
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Adjustments |
|
|
Total |
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
(5,386 |
) |
|
$ |
477 |
|
|
$ |
19,185 |
|
|
$ |
|
|
|
$ |
14,276 |
|
Accounts receivable, net |
|
|
|
|
|
|
68,349 |
|
|
|
24,602 |
|
|
|
|
|
|
|
92,951 |
|
Inventory, net |
|
|
|
|
|
|
48,074 |
|
|
|
35,259 |
|
|
|
(469 |
) |
|
|
82,864 |
|
Other current assets |
|
|
7,607 |
|
|
|
29,954 |
|
|
|
18,606 |
|
|
|
|
|
|
|
56,167 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
2,221 |
|
|
|
146,854 |
|
|
|
97,652 |
|
|
|
(469 |
) |
|
|
246,258 |
|
Property, plant and equipment, net |
|
|
|
|
|
|
61,300 |
|
|
|
30,794 |
|
|
|
|
|
|
|
92,094 |
|
Goodwill |
|
|
|
|
|
|
189,671 |
|
|
|
57,329 |
|
|
|
|
|
|
|
247,000 |
|
Intangible assets, net |
|
|
|
|
|
|
138,727 |
|
|
|
2,225 |
|
|
|
|
|
|
|
140,952 |
|
Investments in affiliates |
|
|
128,872 |
|
|
|
39,827 |
|
|
|
|
|
|
|
(168,699 |
) |
|
|
|
|
Intercompany receivables |
|
|
435,080 |
|
|
|
|
|
|
|
|
|
|
|
(435,080 |
) |
|
|
|
|
Other assets |
|
|
10,614 |
|
|
|
1,671 |
|
|
|
1,227 |
|
|
|
|
|
|
|
13,512 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
576,787 |
|
|
$ |
578,050 |
|
|
$ |
189,227 |
|
|
$ |
(604,248 |
) |
|
$ |
739,816 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS
EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable and accruals |
|
$ |
(5,864 |
) |
|
$ |
111,112 |
|
|
$ |
30,560 |
|
|
$ |
179 |
|
|
$ |
135,987 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
(5,864 |
) |
|
|
111,112 |
|
|
|
30,560 |
|
|
|
179 |
|
|
|
135,987 |
|
Long-term debt |
|
|
250,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250,000 |
|
Intercompany payables |
|
|
|
|
|
|
324,711 |
|
|
|
111,017 |
|
|
|
(435,728 |
) |
|
|
|
|
Other long-term liabilities |
|
|
51,226 |
|
|
|
13,355 |
|
|
|
7,823 |
|
|
|
|
|
|
|
72,404 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities |
|
|
295,362 |
|
|
|
449,178 |
|
|
|
149,400 |
|
|
|
(435,549 |
) |
|
|
458,391 |
|
Common Stock |
|
|
275 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
275 |
|
Other stockholders equity |
|
|
281,150 |
|
|
|
128,872 |
|
|
|
39,827 |
|
|
|
(168,699 |
) |
|
|
281,150 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity |
|
|
281,425 |
|
|
|
128,872 |
|
|
|
39,827 |
|
|
|
(168,699 |
) |
|
|
281,425 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity |
|
$ |
576,787 |
|
|
$ |
578,050 |
|
|
$ |
189,227 |
|
|
$ |
(604,248 |
) |
|
$ |
739,816 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14
CHART INDUSTRIES, INC. AND SUBSIDIARIES
Notes to Unaudited Condensed Consolidated Financial Statements June 30, 2007
(Dollars and shares in thousands, except per share amounts)
CONDENSED CONSOLIDATING BALANCE SHEET (AUDITED)
As of December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary |
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary |
|
|
Non- |
|
|
Consolidating |
|
|
|
|
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Adjustments |
|
|
Total |
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
6,084 |
|
|
$ |
114 |
|
|
$ |
12,656 |
|
|
$ |
|
|
|
$ |
18,854 |
|
Accounts receivable, net |
|
|
|
|
|
|
58,320 |
|
|
|
18,442 |
|
|
|
|
|
|
|
76,762 |
|
Inventory, net |
|
|
|
|
|
|
43,559 |
|
|
|
29,508 |
|
|
|
(210 |
) |
|
|
72,857 |
|
Other current assets |
|
|
8,319 |
|
|
|
39,955 |
|
|
|
13,888 |
|
|
|
|
|
|
|
62,162 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
14,403 |
|
|
|
141,948 |
|
|
|
74,494 |
|
|
|
(210 |
) |
|
|
230,635 |
|
Property, plant and equipment, net |
|
|
|
|
|
|
57,469 |
|
|
|
28,254 |
|
|
|
|
|
|
|
85,723 |
|
Goodwill |
|
|
|
|
|
|
189,671 |
|
|
|
57,473 |
|
|
|
|
|
|
|
247,144 |
|
Intangible assets, net |
|
|
|
|
|
|
143,998 |
|
|
|
2,625 |
|
|
|
|
|
|
|
146,623 |
|
Investments in affiliates |
|
|
104,109 |
|
|
|
38,326 |
|
|
|
|
|
|
|
(142,435 |
) |
|
|
|
|
Intercompany receivables |
|
|
421,549 |
|
|
|
|
|
|
|
|
|
|
|
(421,549 |
) |
|
|
|
|
Other assets |
|
|
11,126 |
|
|
|
1,580 |
|
|
|
2,044 |
|
|
|
|
|
|
|
14,750 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
551,187 |
|
|
$ |
572,992 |
|
|
$ |
164,890 |
|
|
$ |
(564,194 |
) |
|
$ |
724,875 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS
EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable and accruals |
|
$ |
(11,935 |
) |
|
$ |
122,734 |
|
|
$ |
28,908 |
|
|
$ |
(466 |
) |
|
$ |
139,241 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
(11,935 |
) |
|
|
122,734 |
|
|
|
28,908 |
|
|
|
(466 |
) |
|
|
139,241 |
|
Long-term debt |
|
|
290,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
290,000 |
|
Intercompany payables |
|
|
|
|
|
|
332,535 |
|
|
|
88,758 |
|
|
|
(421,293 |
) |
|
|
|
|
Other long-term liabilities |
|
|
53,388 |
|
|
|
13,614 |
|
|
|
8,898 |
|
|
|
|
|
|
|
75,900 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities |
|
|
331,453 |
|
|
|
468,883 |
|
|
|
126,564 |
|
|
|
(421,759 |
) |
|
|
505,141 |
|
Common Stock |
|
|
256 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
256 |
|
Other stockholders equity |
|
|
219,478 |
|
|
|
104,109 |
|
|
|
38,326 |
|
|
|
(142,435 |
) |
|
|
219,478 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity |
|
|
219,734 |
|
|
|
104,109 |
|
|
|
38,326 |
|
|
|
(142,435 |
) |
|
|
219,734 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity |
|
$ |
551,187 |
|
|
$ |
572,992 |
|
|
$ |
164,890 |
|
|
$ |
(564,194 |
) |
|
$ |
724,875 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15
CHART INDUSTRIES, INC. AND SUBSIDIARIES
Notes to Unaudited Condensed Consolidated Financial Statements June 30, 2007
(Dollars and shares in thousands, except per share amounts)
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Three Months Ended June 30, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary |
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary |
|
|
Non- |
|
|
Consolidating |
|
|
|
|
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Adjustments |
|
|
Total |
|
Net sales |
|
$ |
|
|
|
$ |
122,497 |
|
|
|
46,328 |
|
|
$ |
(1,238 |
) |
|
$ |
167,587 |
|
Cost of sales |
|
|
|
|
|
|
82,602 |
|
|
|
34,826 |
|
|
|
(1,099 |
) |
|
|
116,329 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
|
|
|
|
39,895 |
|
|
|
11,502 |
|
|
|
(139 |
) |
|
|
51,258 |
|
Selling, general and administrative expenses |
|
|
97 |
|
|
|
28,040 |
|
|
|
3,372 |
|
|
|
|
|
|
|
31,509 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
|
(97 |
) |
|
|
11,855 |
|
|
|
8,130 |
|
|
|
(139 |
) |
|
|
19,749 |
|
Interest expense |
|
|
6,453 |
|
|
|
(5 |
) |
|
|
(74 |
) |
|
|
|
|
|
|
6,374 |
|
Other (income) expense, net |
|
|
|
|
|
|
(6 |
) |
|
|
590 |
|
|
|
|
|
|
|
584 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes and
equity in net (income) of subsidiaries |
|
|
(6,550 |
) |
|
|
11,866 |
|
|
|
7,614 |
|
|
|
(139 |
) |
|
|
12,791 |
|
Income tax (benefit) provision |
|
|
(2,233 |
) |
|
|
5,786 |
|
|
|
790 |
|
|
|
|
|
|
|
4,343 |
|
Equity in net (income) of subsidiaries |
|
|
(12,765 |
) |
|
|
(6,685 |
) |
|
|
|
|
|
|
19,450 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
8,448 |
|
|
$ |
12,765 |
|
|
$ |
6,824 |
|
|
$ |
(19,589 |
) |
|
$ |
8,448 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Three Months Ended June 30, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary |
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary |
|
|
Non- |
|
|
Consolidating |
|
|
|
|
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Adjustments |
|
|
Total |
|
Net sales |
|
$ |
|
|
|
$ |
98,890 |
|
|
|
31,469 |
|
|
$ |
(992 |
) |
|
$ |
129,367 |
|
Cost of sales |
|
|
|
|
|
|
72,677 |
|
|
|
21,543 |
|
|
|
(966 |
) |
|
|
93,254 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
|
|
|
|
26,213 |
|
|
|
9,926 |
|
|
|
(26 |
) |
|
|
36,113 |
|
Selling, general and administrative expenses |
|
|
208 |
|
|
|
18,889 |
|
|
|
2,193 |
|
|
|
|
|
|
|
21,290 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
|
(208 |
) |
|
|
7,324 |
|
|
|
7,733 |
|
|
|
(26 |
) |
|
|
14,823 |
|
Interest expense |
|
|
6,589 |
|
|
|
(12 |
) |
|
|
9 |
|
|
|
|
|
|
|
6,586 |
|
Other (income) expense, net |
|
|
369 |
|
|
|
72 |
|
|
|
(75 |
) |
|
|
|
|
|
|
366 |
|
Minority interest, net of tax |
|
|
|
|
|
|
|
|
|
|
(53 |
) |
|
|
|
|
|
|
(53 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes and
equity in net (income) of subsidiaries |
|
|
(7,166 |
) |
|
|
7,264 |
|
|
|
7,746 |
|
|
|
(26 |
) |
|
|
7,818 |
|
Income tax provision (benefit) |
|
|
(3,268 |
) |
|
|
4,380 |
|
|
|
1,398 |
|
|
|
|
|
|
|
2,510 |
|
Equity in net (income) of subsidiaries |
|
|
(9,206 |
) |
|
|
(6,322 |
) |
|
|
|
|
|
|
15,528 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
5,308 |
|
|
$ |
9,206 |
|
|
$ |
6,348 |
|
|
$ |
(15,554 |
) |
|
$ |
5,308 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16
CHART INDUSTRIES, INC. AND SUBSIDIARIES
Notes to Unaudited Condensed Consolidated Financial Statements June 30, 2007
(Dollars and shares in thousands, except per share amounts)
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Six Months Ended June 30, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary |
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary |
|
|
Non- |
|
|
Consolidating |
|
|
|
|
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Adjustments |
|
|
Total |
|
Net sales |
|
$ |
|
|
|
$ |
233,965 |
|
|
|
88,384 |
|
|
$ |
(2,299 |
) |
|
$ |
320,050 |
|
Cost of sales |
|
|
|
|
|
|
164,587 |
|
|
|
66,386 |
|
|
|
(2,040 |
) |
|
|
228,933 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
|
|
|
|
69,378 |
|
|
|
21,998 |
|
|
|
(259 |
) |
|
|
91,117 |
|
Selling, general and administrative expenses |
|
|
749 |
|
|
|
47,817 |
|
|
|
5,515 |
|
|
|
|
|
|
|
54,081 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
|
(749 |
) |
|
|
21,561 |
|
|
|
16,483 |
|
|
|
(259 |
) |
|
|
37,036 |
|
Interest expense |
|
|
13,185 |
|
|
|
50 |
|
|
|
(111 |
) |
|
|
|
|
|
|
13,124 |
|
Other (income) expense, net |
|
|
|
|
|
|
47 |
|
|
|
183 |
|
|
|
|
|
|
|
230 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes and
equity in net (income) of subsidiaries |
|
|
(13,934 |
) |
|
|
21,464 |
|
|
|
16,411 |
|
|
|
(259 |
) |
|
|
23,682 |
|
Income tax (benefit) provision |
|
|
(4,752 |
) |
|
|
10,292 |
|
|
|
2,516 |
|
|
|
|
|
|
|
8,056 |
|
Equity in net (income) of subsidiaries |
|
|
(24,808 |
) |
|
|
(13,636 |
) |
|
|
|
|
|
|
38,444 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
15,626 |
|
|
$ |
24,808 |
|
|
$ |
13,895 |
|
|
$ |
(38,703 |
) |
|
$ |
15,626 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Six Months Ended June 30, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary |
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary |
|
|
Non- |
|
|
Consolidating |
|
|
|
|
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Adjustments |
|
|
Total |
|
Net sales |
|
$ |
|
|
|
$ |
191,567 |
|
|
|
60,463 |
|
|
$ |
(1,823 |
) |
|
$ |
250,207 |
|
Cost of sales |
|
|
|
|
|
|
136,259 |
|
|
|
42,551 |
|
|
|
(1,703 |
) |
|
|
177,107 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
|
|
|
|
55,308 |
|
|
|
17,912 |
|
|
|
(120 |
) |
|
|
73,100 |
|
Selling, general and administrative expenses |
|
|
599 |
|
|
|
37,214 |
|
|
|
4,668 |
|
|
|
9 |
|
|
|
42,490 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
|
(599 |
) |
|
|
18,094 |
|
|
|
13,244 |
|
|
|
(129 |
) |
|
|
30,610 |
|
Interest expense |
|
|
13,235 |
|
|
|
(30 |
) |
|
|
(74 |
) |
|
|
|
|
|
|
13,131 |
|
Other (income) expense, net |
|
|
739 |
|
|
|
102 |
|
|
|
(253 |
) |
|
|
|
|
|
|
588 |
|
Minority interest, net of tax |
|
|
|
|
|
|
|
|
|
|
(47 |
) |
|
|
|
|
|
|
(47 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes and
equity in net (income) of subsidiaries |
|
|
(14,573 |
) |
|
|
18,022 |
|
|
|
13,524 |
|
|
|
(129 |
) |
|
|
16,844 |
|
Income tax provision (benefit) |
|
|
(5,712 |
) |
|
|
9,157 |
|
|
|
2,045 |
|
|
|
|
|
|
|
5,490 |
|
Equity in net (income) of subsidiaries |
|
|
(20,215 |
) |
|
|
(11,350 |
) |
|
|
|
|
|
|
31,565 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
11,354 |
|
|
$ |
20,215 |
|
|
$ |
11,479 |
|
|
$ |
(31,694 |
) |
|
$ |
11,354 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17
CHART INDUSTRIES, INC. AND SUBSIDIARIES
Notes to Unaudited Condensed Consolidated Financial Statements June 30, 2007
(Dollars and shares in thousands, except per share amounts)
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Six Months Ended June 30, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary |
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary |
|
|
Non- |
|
|
Consolidating |
|
|
|
|
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Adjustments |
|
|
Total |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by operating activities |
|
$ |
(3,747 |
) |
|
$ |
3,188 |
|
|
$ |
1,082 |
|
|
$ |
7,853 |
|
|
$ |
8,376 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
|
|
|
|
(6,254 |
) |
|
|
(4,337 |
) |
|
|
|
|
|
|
(10,591 |
) |
Acquisition of minority interest and
other assets |
|
|
|
|
|
|
|
|
|
|
(1,649 |
) |
|
|
|
|
|
|
(1,649 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash
(used in) investing activities |
|
|
|
|
|
|
(6,254 |
) |
|
|
(5,986 |
) |
|
|
|
|
|
|
(12,240 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in debt |
|
|
(40,000 |
) |
|
|
(750 |
) |
|
|
|
|
|
|
|
|
|
|
(40,750 |
) |
Proceeds from secondary stock offering, net |
|
|
38,061 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38,061 |
|
Other financing activities |
|
|
452 |
|
|
|
(6,073 |
) |
|
|
7,401 |
|
|
|
|
|
|
|
1,780 |
|
Intercompany account changes |
|
|
(6,236 |
) |
|
|
10,252 |
|
|
|
3,837 |
|
|
|
(7,853 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by financing activities |
|
|
(7,723 |
) |
|
|
3,429 |
|
|
|
11,238 |
|
|
|
(7,853 |
) |
|
|
(909 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash and
cash equivalents |
|
|
(11,470 |
) |
|
|
363 |
|
|
|
6,334 |
|
|
|
|
|
|
|
(4,773 |
) |
Effect of exchange rate changes |
|
|
|
|
|
|
|
|
|
|
195 |
|
|
|
|
|
|
|
195 |
|
Cash and cash equivalents, beginning
of period |
|
|
6,084 |
|
|
|
114 |
|
|
|
12,656 |
|
|
|
|
|
|
|
18,854 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end
of period |
|
$ |
(5,386 |
) |
|
$ |
477 |
|
|
$ |
19,185 |
|
|
$ |
|
|
|
$ |
14,276 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18
CHART INDUSTRIES, INC. AND SUBSIDIARIES
Notes to Unaudited Condensed Consolidated Financial Statements June 30, 2007
(Dollars and shares in thousands, except per share amounts)
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Six Months Ended June 30, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary |
|
|
Subsidiary |
|
|
Consolidating |
|
|
|
|
|
|
Issuer |
|
|
Guarantors |
|
|
Non-Guarantors |
|
|
Adjustments |
|
|
Total |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by
operating activities |
|
$ |
(16,897 |
) |
|
$ |
25,383 |
|
|
$ |
7,971 |
|
|
$ |
(41 |
) |
|
$ |
16,416 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
|
|
|
|
(5,296 |
) |
|
|
(1,944 |
) |
|
|
|
|
|
|
(7,240 |
) |
Acquisition of business, net of cash |
|
|
|
|
|
|
(15,858 |
) |
|
|
|
|
|
|
|
|
|
|
(15,858 |
) |
Other investing activities |
|
|
|
|
|
|
|
|
|
|
(188 |
) |
|
|
|
|
|
|
(188 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in)
investing activities |
|
|
|
|
|
|
(21,154 |
) |
|
|
(2,132 |
) |
|
|
|
|
|
|
(23,286 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in debt |
|
|
(30,000 |
) |
|
|
|
|
|
|
(2,350 |
) |
|
|
|
|
|
|
(32,350 |
) |
Intercompany account changes |
|
|
3,065 |
|
|
|
(3,570 |
) |
|
|
464 |
|
|
|
41 |
|
|
|
|
|
Other financing activities |
|
|
39,237 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
39,237 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in)
financing activities |
|
|
12,302 |
|
|
|
(3,570 |
) |
|
|
(1,886 |
) |
|
|
41 |
|
|
|
6,887 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
(decrease) increase in cash and
cash equivalents |
|
|
(4,595 |
) |
|
|
659 |
|
|
|
3,953 |
|
|
|
|
|
|
|
17 |
|
Effect of exchange rate changes |
|
|
|
|
|
|
|
|
|
|
254 |
|
|
|
|
|
|
|
254 |
|
Cash and cash equivalents, beginning
of period |
|
|
7,191 |
|
|
|
272 |
|
|
|
3,863 |
|
|
|
|
|
|
|
11,326 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end
of period |
|
$ |
2,596 |
|
|
$ |
931 |
|
|
$ |
8,070 |
|
|
$ |
|
|
|
$ |
11,597 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19
Item 2. Managements Discussion and Analysis of Financial Condition and Results of
Operations.
Overview
Chart Industries, Inc. (the Company, Chart, or we) is a leading independent global
manufacturer of highly engineered equipment used in the production, storage and end-use of
hydrocarbon and industrial gases. We supply engineered equipment used throughout the global liquid
supply chain. The largest portion of end-use applications for our products is energy-related. We
are a leading manufacturer of standard and engineered equipment primarily used for low temperature
and cryogenic applications. We have developed an expertise in cryogenic systems and equipment,
which operate at low temperatures sometimes approaching absolute zero (0 kelvin; -273° Centigrade;
- 459° Fahrenheit). The majority of our products, including vacuum-insulated containment vessels,
heat exchangers, cold boxes and other cryogenic components are used throughout the liquid gas
supply chain for the purification, liquefaction, distribution, storage and end-use of hydrocarbon
and industrial gases.
For the six months ended June 30, 2007, orders have remained strong at $418.3 million and
backlog has increased to $415.3 million compared to $319.2 million at December 31, 2006. This
increase is primarily due to increased demand in the global hydrocarbon processing and industrial
gas markets served by our Energy and Chemicals (E&C) and Distribution and Storage (D&S)
segments and continued penetration of the international markets served by our BioMedical segment.
Also, we experienced growth in our sales, gross profit and operating income for the six months
ended June 30, 2007 compared to the same period in 2006, which was primarily attributable to higher
volume across all of our business segments, and the timing of product price increases, particularly
in our D&S segment. Sales for the six months ended June 30, 2007 were $320.1 million compared to
sales of $250.2 million for the six months ended June 30, 2006, reflecting an increase of $69.9
million, or 27.9%. Our gross profit for the six months ended June 30, 2007 was $91.1 million, or
28.5% of sales, as compared to $73.1 million, or 29.2% of sales, for the same period in 2006. In
addition, our operating income for the six months ended June 30, 2007 was $37.0 million compared to
$30.6 million for the same period in 2006. Our slight gross profit margin decline was attributed
to our E&C and BioMedical segments.
As a result of the continued growth in many of the markets we serve, higher product pricing,
our present and anticipated customer order trends and our backlog level of $415.3 million as of
June 30, 2007, we presently expect to experience continued sales and operating income growth for
the remainder of 2007 as compared to the same period in 2006.
However, a temporary slowdown in the D&S segment bulk storage system
sales in the U.S. industrial gas market is anticipated in second half
of 2007 as a result of the Linde/BOC merger. We also
believe that our cash flow from operations, available cash and available borrowings under the
senior secured credit facility should be adequate to meet our working capital, capital expenditure,
debt service and other funding requirements for the remainder of 2007.
20
Results of Operations for the Three Months Ended June 30, 2007 and 2006
The following table sets forth sales, gross profit, gross profit margin and operating income
or loss for our three operating segments for the three and six months ended June 30, 2007 and 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy & Chemicals |
|
$ |
58,092 |
|
|
$ |
42,490 |
|
|
$ |
110,369 |
|
|
$ |
83,664 |
|
Distribution & Storage |
|
|
86,562 |
|
|
|
66,512 |
|
|
|
163,341 |
|
|
|
126,830 |
|
BioMedical |
|
|
22,933 |
|
|
|
20,365 |
|
|
|
46,340 |
|
|
|
39,713 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
167,587 |
|
|
$ |
129,367 |
|
|
$ |
320,050 |
|
|
$ |
250,207 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy & Chemicals |
|
$ |
15,817 |
|
|
$ |
6,213 |
|
|
$ |
21,844 |
|
|
$ |
17,862 |
|
Distribution & Storage |
|
|
27,525 |
|
|
|
22,156 |
|
|
|
53,275 |
|
|
|
40,978 |
|
BioMedical |
|
|
7,916 |
|
|
|
7,744 |
|
|
|
15,998 |
|
|
|
14,260 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
51,258 |
|
|
$ |
36,113 |
|
|
$ |
91,117 |
|
|
$ |
73,100 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit Margin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy & Chemicals |
|
|
27.2 |
% |
|
|
14.6 |
% |
|
|
19.8 |
% |
|
|
21.3 |
% |
Distribution & Storage |
|
|
31.8 |
% |
|
|
33.3 |
% |
|
|
32.6 |
% |
|
|
32.3 |
% |
BioMedical |
|
|
34.5 |
% |
|
|
38.0 |
% |
|
|
34.5 |
% |
|
|
35.9 |
% |
Total |
|
|
30.6 |
% |
|
|
27.9 |
% |
|
|
28.5 |
% |
|
|
29.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Income (Loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy & Chemicals |
|
$ |
9,717 |
|
|
$ |
1,109 |
|
|
$ |
9,867 |
|
|
$ |
7,043 |
|
Distribution & Storage |
|
|
19,153 |
|
|
|
14,270 |
|
|
|
37,197 |
|
|
|
25,347 |
|
BioMedical |
|
|
4,847 |
|
|
|
4,777 |
|
|
|
9,757 |
|
|
|
8,491 |
|
Corporate |
|
|
(13,968 |
) |
|
|
(5,333 |
) |
|
|
(19,785 |
) |
|
|
(10,271 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
19,749 |
|
|
$ |
14,823 |
|
|
$ |
37,036 |
|
|
$ |
30,610 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
Sales for the three months ended June 30, 2007 were $167.6 million compared to $129.4 million
for the three months ended June 30, 2006, reflecting an increase of $38.2 million, or 29.5%. E&C
segment sales were $58.1 million for the three months ended June 30, 2007 compared with sales of
$42.5 million for three months ended June 30, 2006, which reflected an increase of $15.6 million or
36.7%. This increase in sales resulted primarily from $7.7 million of air cooled heat exchanger
sales from Cooler Service Company (CSC), which was acquired in the second quarter of 2006, and
from higher volume for brazed aluminum heat exchangers. D&S segment sales increased $20.1 million,
or 30.2%, to $86.6 million for the three months ended June 30, 2007 from $66.5 million for the
three months ended June 30, 2006. Sales of bulk storage systems and packaged gas systems increased
$16.4 million and $3.7 million, respectively, for the three months ended June 30, 2007 compared to
the same period in 2006, primarily due to higher volume as a result of continued growth in the
global industrial gas market, and price increases to absorb escalating raw material costs. Another
contributing factor to the increased D&S segment sales in the second quarter of 2007 compared with the same
period in 2006 was favorable foreign currency translation of approximately $2.1 million as a result
of the weakened U.S. dollar compared to the Euro and Czech Koruna. BioMedical segment sales for
the three months ended June 30, 2007 were $22.9 million compared to $20.4 million for the same
period in 2006, which reflected an increase of $2.5 million or 12.3%. Biological storage system
sales increased $2.6 million primarily due to higher volume in international markets.
21
Gross Profit and Margin
Gross profit for the three months ended June 30, 2007 was $51.3 million, or 30.6% of sales,
versus $36.1 million, or 27.9% of sales, for the three months ended June 30, 2006 and reflected an
increase of $15.2 million. E&C segment gross profit increased $9.6 million and its margin
increased 12.6 percentage points, primarily due to a favorable change in project mix for process
systems. The improvement in gross profit is also due to higher sales volume in heat exchangers
and the acquisition of CSC in the second quarter of 2006. Gross profit for the D&S segment
increased $5.3 million, as the margin declined 1.5 percentage points, in the 2007 three month
period compared to the 2006 three month period. The increase in gross profit is due to higher
sales volume and to a lesser extent the timing of product price increases in both bulk storage and
packaged gas systems to absorb escalating raw material costs. The decrease in the D&S segment
margin was caused by a change in product line sales mix. BioMedical gross profit increased $0.2 million due
to higher sales volume in international markets for both medical respiratory products and
biological storage systems. However, the margin decreased 3.5 percentage points in the 2007 period
compared to the 2006 period due to an unfavorable sales volume in domestic markets and raw material
surcharges.
Selling, General and Administrative Expenses (SG&A)
SG&A expenses for the three months ended June 30, 2007 were $28.8 million, or 17.2% of sales,
compared to $17.7 million, or 13.7% of sales, for the three months ended June 30, 2006. SG&A
expenses for the E&C segment were $5.2 million for the three months ended June 30, 2007 compared to
$3.7 million for the three months ended June 30, 2006, an increase of $1.5 million. The increase
for the E&C segment was primarily the result of higher employee-related and infrastructure expenses
to support business growth. D&S segment SG&A expenses for the three months ended June 30, 2007
were $7.1 million compared to $6.0 million for the three months ended June 30, 2006, an increase of
$1.1 million. This increase was primarily attributable to higher employee-related and
infrastructure costs to support business growth. SG&A expenses for the BioMedical segment were
$2.6 million for the three months ended June 30, 2007 and the three months ended June 30, 2006.
Corporate SG&A expenses for the three months ended June 30, 2007 were $13.9 million compared to
$5.4 million for the three months ended June 30, 2006. This increase of $8.5 million was primarily
attributable to $7.1 million in stock-based compensation expense related primarily to the vesting
of the performance-based options in conjunction with the secondary
stock offering completed in June 2007.
Also contributing to the increase in SG&A expenses was the incurrence of Sarbanes-Oxley
implementation costs and secondary stock offering expenses
aggregating approximately $0.9 million, other public company
expenses, and infrastructure support costs.
Amortization Expense
Amortization expense for the three months ended June 30, 2007 was $2.6 million, or 1.5% of
sales, compared to $3.5 million, or 2.7% of sales for the three months ended June 30, 2006. The
decrease of $0.9 million was due to certain intangible assets being fully amortized at June 30,
2007.
Employee Separation and Plant Closure Costs
For both the three months ended June 30, 2007 and 2006, employee separation and plant closure
costs were $0.1 million. The costs for both periods were related to the idle Plaistow, New
Hampshire facility that is being held for sale. The sale of this facility is expected to be
completed by the end of 2007.
Operating Income
As a result of the foregoing, operating income for the three months ended June 30, 2007 was
$19.7 million, or 11.8% of sales, an increase of $4.9 million compared to operating income of $14.8
million, or 11.4% of sales, for the same period in 2006.
Net Interest Expense
Net interest expense for the three months ended June 30, 2007 and 2006 was $6.0 million and
$6.6 million, respectively. The decrease in interest expense of $0.6 million for the three months
ended June 30, 2007 compared to the same period in 2006 was primarily attributable to decreased
long-term debt outstanding as a result of voluntary principal payments of $90.0 million made on the
term loan portion of our senior secured credit facility (Senior Credit Facility), funded
primarily by proceeds from warrant and option exercises in the second quarter of 2006, the
Companys initial public offering (IPO) in 2006 and proceeds from the secondary offering
completed in June 2007. This decrease was partially offset by higher interest rates on our Senior
Credit Facility and the interest incurred on borrowings on the revolving portion of the Senior
Credit Facility.
22
Other Expense and Income
Financing costs amortization were $0.4 million for both the three months ended June 30, 2007
and 2006, respectively.
For the three months ended June 30, 2007, foreign currency losses were $0.6 million as
compared to minimal foreign currency gains for the same period in 2006. This decrease in income
was the result of the timing of transactions in currencies other than functional currencies
primarily in the D&S and BioMedical segments.
Income Tax Expense
Income tax expense of $4.3 million and $2.5 million for the three months ended June 30, 2007
and 2006, respectively, represents taxes on both U.S. and foreign earnings at an effective income
tax rate of 34.1% and 31.9%, respectively. The increase in the effective income tax rate was
primarily due to a greater proportion of U.S. earnings that are taxed at higher rates than the
Companys foreign earnings.
Net Income
As a result of the foregoing, reported net income for the three months ended June 30, 2007 and
2006 was $8.4 million and $5.3 million, respectively.
Results of Operations for the Six Months Ended June 30, 2007 and 2006
Sales
Sales for the six months ended June 30, 2007 were $320.1 million compared to $250.2 million
for the six months ended June 30, 2006, reflecting an increase of $69.9 million, or 27.9%. E&C
segment sales were $110.4 million for the six months ended June 30, 2007 compared with sales of
$83.7 million for the same period in 2006, which represented an increase of $26.7 million, or
31.9%. This increase in sales resulted primarily from higher volume, particularly from larger
projects, in both heat exchangers and process systems, which were driven by continued growth in the
liquefied natural gas (LNG) and natural gas segments of the hydrocarbon processing market, and
an additional $17.6 million of sales from CSC, which was acquired in the second quarter of 2006. D&S
segment sales increased $36.6 million, or 28.8%, to $163.4 million for the six months ended June
30, 2007 from $126.8 million for the six months ended June 30, 2007. Bulk storage and packaged gas
systems sales increased $28.9 million and $7.7 million, respectively, for the six months ended June
30, 2007 compared to the same period in 2006. These increases were driven primarily by increased
volume due to continued growth in the global industrial gas market,
higher product pricing, and favorable foreign currency translation as
a result of the weakened U.S. dollar compared to the Euro and Czech
Koruna.
BioMedical segment sales increased $6.6 million, or 16.6%, to $46.3 million for the six months
ended June 30, 2007 compared to $39.7 million for the six months ended June 30, 2006. Biological
storage systems sales increased $4.3 million as a result of higher volume in the U.S. and
international markets. MRI and other product sales increased $1.3 million due to higher volume.
Medical respiratory product sales increased $1.0 million as a result of increased demand in the
international markets partially offset by decreased demand in the U.S. market due to U.S.
government reimbursement reductions for oxygen therapy systems.
Gross Profit and Margin
Gross profit for the six months ended June 30, 2007 was $91.1 million, or 28.5% of sales,
versus $73.1 million, or 29.2% of sales, for the six months ended June 30, 2006 and reflected an
increase of $18.0 million. E&C segment gross profit increased $4.0 million in the 2007 period
compared to the 2006 period primarily due to increased sales volume in brazed aluminum and
air-cooled heat exchangers. The E&C segment gross profit margin decreased 1.5 percentage points in
2007 primarily due to previously disclosed lower margins on two large, complex field installation
projects, lost productivity at the La Crosse, Wisconsin brazed aluminum heat exchanger facility as
a result of a settled strike in February 2007 and lower margins on several other fixed price
contracts that were completed or near completion at March 31, 2007. This decline was partially
offset by improved margins for both brazed aluminum and air-cooled heat exchangers. Gross profit
for the D&S segment increased $12.2 million, or 0.3 percentage points, in the 2007 period compared
to the 2006 period primarily due to higher sales volume, manufacturing productivity improvements
and to a lesser extent the timing of product price increases to absorb higher raw material costs in
bulk storage and packaged gas systems. These were partially offset by
a product line sales mix
shift. BioMedical gross profit increased $1.7 million in the 2007 period compared to the 2006
period primarily due to higher sales volume. The BioMedical gross profit margin decreased 1.4
percentage points in 2007 primarily due to increases in raw material costs.
23
SG&A
SG&A expenses for the six months ended June 30, 2007 were $48.2 million, or 15.1% of sales,
versus $35.2 million, or 14.1% of sales, for the six months ended June 30, 2006. SG&A expenses for
the E&C segment were $9.7 million for the six months ended June 30, 2007 compared to $8.1 million
for the six months ended June 30, 2006, an increase of $1.6 million. The increase for the E&C
segment was primarily the result of higher employee-related and infrastructure expenses to support
business growth, increased commission expense due to higher sales volume and the inclusion of CSC
for the full six months. D&S segment SG&A expenses for the six months ended June 30, 2007 were
$13.5 million compared to $11.8 million for the six months ended June 30, 2006, an increase of $1.7
million. This increase was primarily attributable to higher employee-related expenses to support
business growth. SG&A expenses for the BioMedical segment were $5.4 million for the six months
ended June 30, 2007, an increase of $0.4 million compared to the six months ended June 30, 2006.
Corporate SG&A expenses for the six months ended June 30, 2007 were $19.5 million compared to $10.3
million for the six months ended June 30, 2006. This increase of $9.2 million was primarily
attributable to $7.1 million in stock-based compensation expense related primarily to the vesting
of the performance-based options in conjunction with the secondary
stock offering completed in June 2007.
Also contributing to the increase was the incurrence of approximately $1.6 million of
Sarbanes-Oxley implementation costs and secondary stock offering
expenses, other public company expenses, and infrastructure support costs.
Amortization Expense
Amortization expense for the six months ended June 30, 2007 was $5.7 million, or 1.8% of
sales, compared to $7.1 million, or 2.8% of sales, for the six months ended June 30, 2006. The
decrease of $1.4 million was due to certain intangible assets being fully amortized.
Employee Separation and Plant Closure Costs
For the six months ended June 30, 2007 and 2006, employee separation and plant closure costs
were $0.1 million and $0.2 million, respectively. The costs for the both periods were related to
the idle Plaistow, New Hampshire facility which is being held for sale. The sale of this facility
is expected to be completed by the end of 2007.
Operating Income
As a result of the foregoing, operating income for the six months ended June 30, 2007 was
$37.0 million, or 11.6% of sales, an increase of $6.4 million compared to operating income of $30.6
million, or 12.2% of sales, for the same period in 2006.
Net Interest Expense
Net interest expense for the six months ended June 30, 2007 and 2006 was $12.3 million and
$13.1 million, respectively. This decrease in interest expense of $0.8 million for the six months
ended June 30, 2007 compared to the same period in 2006 was primarily attributable to decreased
long-term debt outstanding as a result of voluntary principal payments of $90.0 million made on the
Term Loan portion of our Senior Credit Facility, funded primarily by proceeds from warrant and
option exercises, the Companys IPO in 2006 and proceeds from
the secondary stock offering completed in
June 2007. This decrease was partially offset by higher interest rates on our Senior Credit
Facility and the additional interest incurred on the Subordinated Notes, since the exchange
offering was not completed until April 2007.
Other Expenses and Income
For the six months ended June 30, 2007 and 2006, financing costs amortization expense was $0.8
million and $0.7 million, respectively. This increase in amortization expense was attributable to
additional deferred loan costs incurred for the amendment on the Senior Credit Facility.
Income Tax Expense
Income tax expense of $8.1 million and $5.5 million for the six months ended June 30, 2007 and
2006, respectively, represents taxes on both domestic and foreign earnings at an annual effective
income tax rate of 34.1% and 32.5%, respectively. The increase in the annual effective income tax
rate was primarily due to a greater proportion of U.S. earnings that are taxed at higher rates than
the Companys foreign earnings.
24
Net Income
As a result of the foregoing, reported net income for the six months ended June 30, 2007 and
2006 was $15.6 million and $11.4 million, respectively.
Liquidity and Capital Resources
Debt Instruments and Related Covenants
As of June 30, 2007, the Company had $80.0 million outstanding under the Term Loan portion of
the Senior Credit Facility, $170.0 million outstanding under the Subordinated Notes and $27.0
million of letters of credit and bank guarantees supported by the revolving portion of the Senior
Credit Facility. The Company believes it is in compliance with all covenants, including its
financial covenants, under the Senior Credit Facility and Subordinated Notes. Availability on the
revolving portion of the Senior Credit Facility was $88.0 million at June 30, 2007.
The registration rights agreement related to the Subordinated Notes required the Company to
file an Exchange Offer Registration Statement and complete the exchange offer for the Subordinated
Notes by August 14, 2006. Since the exchange offer was not completed when required, additional
interest at a rate of 0.50% was incurred for the 90-day period commencing November 12, 2006 and
additional interest at a rate of 0.75% was incurred for the 90-day period commencing February 10,
2007. The exchange offer was completed on April 6, 2007 and the additional interest ceased
accruing as of that date.
Sources and Use of Cash
Cash
provided by operations for the six months ended June 30, 2007 was $8.4 million compared
with cash provided by operations of $16.4 million for the six months ended June 30, 2006. The
change in the cash provided by operations in the 2007 period was attributable to increased
working capital levels, primarily accounts receivable and inventory to support business growth.
Cash used in investing activities for the six months ended June 30, 2007 was $12.2 million
compared to $23.3 million for the six months ended June 30, 2006. Capital expenditures for the six
months ended June 30, 2007 were $10.6 million compared with $7.2 million for the six months ended
June 30, 2006. Capital expenditures for 2007 were primarily for the E&C segment brazed aluminum
heat exchanger facility expansion in La Crosse, Wisconsin and D&S segment expansion in China to
support business growth. Capital expenditures during the same period in 2006 were primarily for
expansion of various existing facilities. For the six months ended June 30, 2007, $1.6 million of cash was
used to purchase the remaining minority interest in Chart Ferox a.s. Also, for the six months
ended June 30, 2006, $15.9 million of cash was used to purchase CSC.
For
the six months ended June 30, 2007, cash used in financing
activities was $0.9 million
compared to cash provided of $6.9 million for the six months ended June 30, 2006. For the six
months ended June 30, 2007 and 2006, $40.0 million and $30.0 million, respectively, were used for
voluntary principal prepayments under the Term Loan portion of our Senior Credit Facility. In
2007, $38.1 million in net proceeds was received from the exercise of the underwriters
over-allotment option in conjunction with the secondary stock offering completed in June. In 2006, $39.2
million in proceeds was received from warrant and option exercises in conjunction with the IPO. In
May 2007, the Company received $1.3 million in contributions from its joint venture partners to
fund a new joint venture based in China for the manufacture of cryogenic trailers.
Cash Requirements
The Company does not anticipate any unusual cash requirements for working capital needs, but
expects to use $13.0 to $15.0 million of cash for capital expenditures for the remaining six months
of 2007. A significant portion of the capital expenditures are expected to be used for continued
facility expansions to increase capacity at the E&C segment La Crosse, Wisconsin facility and the
D&S segment China, Czech Republic and New Prague, Minnesota facilities. Management believes that
these expansions are necessary to support our current backlog levels and our expected growth due to
an increase in global demand for our products.
For the remaining six months of 2007, cash requirements for debt service are forecasted to be
approximately $10.0 million for scheduled interest payments under our Senior Credit Facility and
the Subordinated Notes. We are not required to make any scheduled principal payments during the
remaining six months of 2007 under the Term Loan portion of the Senior Credit Facility or
Subordinated Notes, but we will consider making voluntary principal payments on our Senior Credit
Facility or repurchasing our Subordinated Notes on the open market to the extent permitted by our
debt covenants with excess cash flow that is generated. For the remainder of 2007, we expect to
use approximately $12.0 million of cash for both U.S. and foreign income taxes and contribute approximately $0.4 million of cash to our
four defined benefit pension plans to meet ERISA minimum funding requirements.
25
Orders and Backlog
We consider orders to be those for which we have received a firm signed purchase order or
other written contractual commitment from the customer. Backlog is comprised of the portion of
firm signed purchase orders or other written contractual commitments received from customers that
the Company has not recognized as revenue under the percentage of completion method or based upon
shipment. Backlog can be significantly affected by the timing of orders for large projects,
particularly in the E&C segment, and it is not necessarily indicative of future backlog levels or
the rate at which backlog will be recognized as sales. Orders included in our backlog may include
customary cancellation provisions under which the customer could cancel part or all of the order at
times subject to the payment of certain costs and/or penalties. Backlog as of June 30, 2007 was
$415.3 million compared to $342.2 million as of March 31, 2007.
The following table sets forth orders and backlog by segment for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
June 30, |
|
|
March 31, |
|
|
|
2007 |
|
|
2007 |
|
Orders |
|
|
|
|
|
|
|
|
Energy and Chemicals |
|
$ |
146,447 |
|
|
$ |
71,310 |
|
Distribution and Storage |
|
|
75,997 |
|
|
|
76,568 |
|
BioMedical |
|
|
21,014 |
|
|
|
26,935 |
|
|
|
|
|
|
|
|
Total |
|
$ |
243,458 |
|
|
$ |
174,813 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Backlog |
|
|
|
|
|
|
|
|
Energy and Chemicals |
|
$ |
315,034 |
|
|
$ |
226,696 |
|
Distribution and Storage |
|
|
92,586 |
|
|
|
105,666 |
|
BioMedical |
|
|
7,653 |
|
|
|
9,820 |
|
|
|
|
|
|
|
|
Total |
|
$ |
415,273 |
|
|
$ |
342,182 |
|
|
|
|
|
|
|
|
E&C orders for the three months ended June 30, 2007 were $146.4 million compared to $71.3
million for the three months ended March 31, 2007. E&C backlog totaled $315.0 million at June 30,
2007 compared to $226.7 million at March 31, 2007. The increase in orders of $75.1 million, or
105%, was primarily attributable to the receipt of process system orders totaling in excess of
$100.0 million in the second quarter of 2007 for four LNG
liquefaction trains to be installed by the customer in
Southeast Asia.
D&S orders for the three months ended June 30, 2007 were $76.0 million compared to $76.6
million for the three months ended March 31, 2007. D&S backlog totaled $92.6 million at June 30,
2007 compared to $105.7 million at March 31, 2007. The D&S backlog declined primarily due to the
strong sales for the three months ended June 30, 2007. Overall, D&S orders have remained strong in
recent quarters due to continued demand in the global industrial gas market. Both bulk storage
systems and packaged gas systems orders for the three months ended June 30, 2007 have remained
relatively constant compared to the three months ended March 31, 2007.
BioMedical orders for the three months ended June 30, 2007 were $21.0 million compared to
$26.9 million for the three months ended March 31, 2007. BioMedical backlog at June 30, 2007
totaled $7.7 million compared to $9.8 million at March 31, 2007. The decrease in orders of $5.9
million, or 21.6%, was primarily due to the timing of larger orders for the three months ended March 31, 2007
were extremely strong across all product lines.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements as defined in the Securities Act.
Application of Critical Accounting Policies
The Companys unaudited condensed consolidated financial statements have been prepared in
accordance with U.S. generally accepted accounting principles. As such, some accounting policies
have a significant impact on amounts reported in these unaudited condensed consolidated financial
statements. A summary of those significant accounting policies can be found in the Companys
Annual Report on Form 10-K for the year ended December 31, 2006. In particular, judgment is used
in areas such as revenue recognition for long-term contracts, determining the allowance for
doubtful accounts, inventory valuation reserves, goodwill, indefinite lived intangibles,
environmental remediation obligations, product warranty costs, debt covenants, pensions and
deferred tax assets. There have been no significant changes in accounting
26
policies since December 31, 2006, except for the adoption on January 1, 2007 of FIN 48 as it relates to the accounting for
income taxes. The adoption of FIN 48 did not have a material effect on the Companys financial
position, results of operations or cash flows.
Forward-Looking Statements
The Company is making this statement in order to satisfy the safe harbor provisions
contained in the Private Securities Litigation Reform Act of 1995. This Quarterly Report on Form
10-Q includes forward-looking statements. These forward-looking statements include statements
relating to our business. In some cases, forward-looking statements may be identified by
terminology such as may, will, should, expects, anticipates, believes, projects,
forecasts, continue, or the negative of such terms or comparable terminology. Forward-looking
statements contained herein (including future cash contractual obligations) or in other statements
made by us are made based on managements expectations and beliefs concerning future events
impacting us and are subject to uncertainties and factors relating to our operations and business
environment, all of which are difficult to predict and many of which are beyond our control, that
could cause our actual results to differ materially from those matters expressed or implied by
forward-looking statements. We believe that the following factors, among others (including those
described in our Risk Factors disclosure), could affect our future performance and the liquidity
and value of our securities and cause our actual results to differ materially from those expressed
or implied by forward-looking statements made by us or on our behalf:
|
|
|
the cyclicality of the markets which we serve; |
|
|
|
|
the loss of, or a significant reduction in purchases by, our largest customers; |
|
|
|
|
competition in our markets; |
|
|
|
|
our compliance obligations with the Sarbanes-Oxley Act of 2002; |
|
|
|
|
general economic, political, business and market risks associated with our non-U.S. operations; |
|
|
|
|
our ability to successfully manage our growth; |
|
|
|
|
the loss of key employees; |
|
|
|
|
the pricing and availability of raw materials and our ability to manage our
fixed-price contract exposure, including exposure to fixed pricing in long-term
customer contracts; |
|
|
|
|
our ability to successfully acquire or integrate companies that provide
complementary products or technologies; |
|
|
|
|
our ability to continue our technical innovation in our product lines; |
|
|
|
|
the impairment of our goodwill and other indefinite-lived intangible assets; |
|
|
|
|
the costs of compliance with environmental, health and safety laws and responding to
potential liabilities under these laws; |
|
|
|
|
the insolvency of our formerly consolidated subsidiary, Chart Heat Exchangers
Limited, or CHEL, and CHELs administration proceedings in the United kingdom,
including claims that may be asserted against us with respect to CHELs obligations; |
|
|
|
|
litigation and disputes involving us, including the extent of product liability,
warranty, pension and severance claims asserted against us; |
|
|
|
|
labor costs and disputes; |
|
|
|
|
our relations with our employees; |
|
|
|
|
our funding requirements in connection with our defined benefit pension plans; |
|
|
|
|
fluctuations in foreign currency exchange and interest rates; |
|
|
|
|
disruptions in our operations due to hurricanes; |
|
|
|
|
our ability to protect our intellectual property and know-how; |
27
|
|
|
regulations governing the export of our products; |
|
|
|
|
additional liabilities related to taxes; and |
|
|
|
|
risks associated with our substantial indebtedness, leverage, debt service and liquidity. |
There may be other factors that may cause our actual results to differ materially from the
forward-looking statements.
All forward-looking statements attributable to us or persons acting on our behalf apply only
as of the date of this Quarterly Report and are expressly qualified in their entirety by the
cautionary statements included in our Annual Report on Form 10-K for 2006 and our definitive
prospectus filed with the Securities and Exchange Commission on June 7, 2007. We undertake no
obligation to update or revise forward-looking statements, which may be made to reflect events or
circumstances that arise after the date made or to reflect the occurrence of unanticipated events.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
In the normal course of business, the Companys operations are exposed to continuing
fluctuations in foreign currency values and interest rates that can affect the cost of operating
and financing. Accordingly, the Company addresses a portion of these risks through a program of
risk management.
The Companys primary interest rate risk exposure results from the various floating rate
pricing mechanisms on the Senior Credit Facility. If interest rates were to increase 200 basis
points (2 percent) from June 30, 2007 rates, and assuming no changes in debt from the June 30, 2007
levels, the additional annual expense would be approximately $1.6 million on a pre-tax basis.
The Company has assets, liabilities and cash flows in foreign currencies creating exposure to
foreign currency exchange fluctuations in the normal course of business. Charts primary exchange
rate exposure is with the Euro, the British pound, the Czech koruna and the Chinese yuan. Monthly
measurement, evaluation and forward exchange rate contracts are employed as methods to reduce this
risk. The Company enters into foreign exchange forward contracts to hedge anticipated and firmly
committed foreign currency transactions. Chart does not use derivative financial instruments for
speculative or trading purposes. The terms of the contracts are one year or less. The Company
held immaterial positions in foreign exchange forward contracts at June 30, 2007.
Item 4. Controls and Procedures
As of June 30, 2007, an evaluation was performed, under the supervision and with the
participation of the Companys management including the Companys Chief Executive Officer and Chief
Financial Officer, of the effectiveness of the design and operation of the Companys disclosure
controls and procedures pursuant to Rule 13a-15 under the Securities
and Exchange Act of 1934, as amended (the Exchange Act). Based upon that evaluation, such
officers concluded that the Companys disclosure controls and procedures are effective to ensure
that information required to be disclosed by the Company in the reports it files or submits under
the Exchange Act (1) is recorded, processed, summarized and reported, within the time periods
specified in the Securities and Exchange Commissions rules and forms and (2) is accumulated and
communicated to the Companys management including the Chief Executive Officer and Chief Financial
Officer, as appropriate to allow for timely decisions regarding required disclosure.
There were no changes in the Companys internal control over financial reporting that occurred
during the Companys most recent fiscal quarter that have materially affected, or are reasonably
likely to materially affect, the Companys internal control over financial reporting.
28
PART II. OTHER INFORMATION
Item 1A. Risk Factors
There have not been any material changes from the risk factors disclosed in the Companys
Annual Report on Form 10-K for the year ended December 31, 2006, except to the extent set forth
under the captions Risk Factors Risks Related to our Business and Risk Factors Risks
Related to our Leverage in the Companys definitive prospectus filed with the Securities and
Exchange Commission under Rule 424 on June 7, 2007.
Item 4. Submission of Matters to a Vote of Security Holders
The Chart Industries Inc. annual meeting of stockholders was held on May 23, 2007. At the
meeting, the election of directors was submitted to a vote of stockholders.
As of the record date of March 30, 2007, there were 25,588,835 shares of common stock
outstanding and entitled to vote at the meeting. The holders of 23,693,719 shares were represented
in person or by proxy at the meeting, constituting a quorum. The vote with respect to the election
of directors submitted to stockholders was as follows:
|
|
|
|
|
|
|
|
|
Election of Directors |
|
For |
|
Withheld |
|
|
|
Samuel F. Thomas |
|
|
20,499,876 |
|
|
|
3,193,843 |
|
Kenneth W. Moore |
|
|
20,323,449 |
|
|
|
3,370,270 |
|
Timothy H. Day |
|
|
20,323,449 |
|
|
|
3,370,270 |
|
Steven W. Krablin |
|
|
22,999,072 |
|
|
|
694,647 |
|
Michael W. Press |
|
|
22,999,072 |
|
|
|
694,647 |
|
Richard E. Goodrich |
|
|
23,031,321 |
|
|
|
662,398 |
|
29
Item 6. Exhibits
The following exhibits are filed with this report:
|
3.1 |
|
Amended and Restated By-Laws, as amended |
|
|
31.1 |
|
Rule 13a-14(a) Certification of Chief Executive Officer |
|
|
31.2 |
|
Rule 13a-14(a) Certification of Chief Financial Officer |
|
|
32.1 |
|
Section 1350 Certification of Chief Executive Officer |
|
|
32.2 |
|
Section 1350 Certification of Chief Financial Officer |
30
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
Chart Industries, Inc. |
|
(Registrant)
|
|
Date: August 13, 2007 |
By: |
/s/ Michael F. Biehl
|
|
|
|
Michael F. Biehl |
|
|
|
Executive Vice President, Chief Financial Officer and Treasurer
(Principal Financial Officer)
(Duly Authorized Officer) |
|
|
31